.Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01E_ProteinKinaseInhibitors

Contents

Name	Description
L01EA01_Imatinib
L01EA02_Dasatinib
L01EA03_Nilotinib
L01EA04_Bosutinib
L01EA05_Ponatinib
L01EA06_Asciminib
L01EB01_Gefitinib
L01EB02_Erlotinib
L01EB03_Afatinib
L01EB04_Osimertinib
L01EB05_Rociletinib
L01EB06_Olmutinib
L01EB07_Dacomitinib
L01EB08_Icotinib
L01EB09_Lazertinib
L01EB10_Mobocertinib
L01EB11_Aumolertinib
L01EC01_Vemurafenib
L01EC02_Dabrafenib
L01EC03_Encorafenib
L01ED01_Crizotinib
L01ED02_Ceritinib
L01ED03_Alectinib
L01ED04_Brigatinib
L01ED05_Lorlatinib
L01EE01_Trametinib
L01EE02_Cobimetinib
L01EE03_Binimetinib
L01EE04_Selumetinib
L01EF01_Palbociclib
L01EF02_Ribociclib
L01EF03_Abemaciclib
L01EG01_Temsirolimus
L01EG02_Everolimus
L01EG03_Ridaforolimus
L01EG04_Sirolimus
L01EH01_Lapatinib
L01EH02_Neratinib
L01EH03_Tucatinib
L01EJ01_Ruxolitinib
L01EJ02_Fedratinib
L01EJ03_Pacritinib
L01EJ04_Momelotinib
L01EK01_Axitinib
L01EK02_Cediranib
L01EK03_Tivozanib
L01EK04_Fruquintinib
L01EL01_Ibrutinib
L01EL02_Acalabrutinib
L01EL03_Zanubrutinib
L01EL04_Orelabrutinib
L01EL05_Pirtobrutinib
L01EM01_Idelalisib
L01EM02_Copanlisib
L01EM03_Alpelisib
L01EM04_Duvelisib
L01EM05_Parsaclisib
L01EN01_Erdafitinib
L01EN02_Pemigatinib
L01EN03_Infigratinib
L01EN04_Futibatinib
L01EX01_Sunitinib
L01EX02_Sorafenib
L01EX03_Pazopanib
L01EX04_Vandetanib
L01EX05_Regorafenib
L01EX06_Masitinib
L01EX07_Cabozantinib
L01EX08_Lenvatinib
L01EX09_Nintedanib
L01EX10_Midostaurin
L01EX11_Quizartinib
L01EX12_Larotrectinib
L01EX13_Gilteritinib
L01EX14_Entrectinib
L01EX15_Pexidartinib
L01EX17_Capmatinib
L01EX18_Avapritinib
L01EX19_Ripretinib
L01EX21_Tepotinib
L01EX22_Selpercatinib
L01EX23_Pralsetinib
L01EX24_Surufatinib
L01EX25_Umbralisib
L01EX26_Sitravatinib
L01EX27_Capivasertib